Human Rights Responsibility & UK Modern Slavery Act
Statement for FY2017

 

(CryoLife is providing this statement voluntarily)

 

CryoLife, Inc. (“CryoLife”), a US company, is headquartered in suburban Atlanta, Georgia, with subsidiaries in the US, Canada, and the European Union, including the UK. It is a leader in the manufacturing, processing and distribution of medical devices and implantable living tissues used in cardiac and vascular surgical procedures focused on aortic repair. CryoLife markets and sells products in more than 90 countries worldwide, including the UK, and relies on suppliers principally in the US and the European Union.

It is CryoLife policy to comply with the laws and regulations applicable to CryoLife business activities around the world. The CryoLife Code of Conduct addresses our corporate citizenship goals, which include acting with the highest integrity in business dealings and serving as a corporate role model in responsible corporate citizenship, including as a contributor to the communities in which we reside and do business.

CryoLife has a comprehensive global compliance program and is committed to ensuring that our global operations comply with legal requirements, such as the California Transparency in Supply Chains Act and the UK Modern Slavery Act.

CryoLife continually improves its processes to assess and ensure that suppliers comply with CryoLife policies and goals, including CryoLife’s human rights responsibility aspirations.

CryoLife suppliers were required in 2017 and are required now to operate in compliance with all applicable laws, regulations, governmental requirements and industry guidelines in the countries in which they operate. In addition, noncompliance with our company Code of Conduct may result in corrective action or termination of a supplier partnership, depending on the severity and frequency of the noncompliance. We may work with suppliers to ensure corrective action plans to resolve any instances of noncompliance.

CryoLife plans to monitor suppliers based on an assessment of the level of risk of slave labor, human trafficking practices or exploitation in high risk countries where suppliers operate. We currently do not believe that parts of our business or supply chains operate in countries where there is significant risk of slavery and human trafficking. In addition, we seek out suppliers and business partners with reputations for ethical and legally compliant business practices, further reducing the risk of exposure to slavery and human trafficking issues.

Based on this risk assessment, including of the material being sourced and its country of origin, CryoLife may request that suppliers certify that materials incorporated into our products comply with the laws regarding slavery and human trafficking of the countries in which the suppliers do business.

Finally, CryoLife employees receive annual training on the Code of Conduct. CryoLife plans on developing training programs on human trafficking for employees who have direct responsibility for supply chain management in which there is a more than an immaterial risk of human trafficking or slavery.

Pat Mackin
Chairman, President, & CEO